Volume 5; Issue 4

The Lancet Diabetes & Endocrinology

Volume 5; Issue 4

1

Oestrogen and anti-androgen therapy for transgender women

Tangpricha, Vin, den Heijer, Martin

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 214 KB

english, 2017

2

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study

Bally, Lia, Thabit, Hood, Kojzar, Harald, Mader, Julia K, Qerimi-Hyseni, Jehona, Hartnell, Sara, Tauschmann, Martin, Allen, Janet M, Wilinska, Malgorzata E, Pieber, Thomas R, Evans, Mark L, Hovorka, R

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 647 KB

english, 2017

3

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

Sorli, Christopher, Harashima, Shin-ichi, Tsoukas, George M, Unger, Jeffrey, Karsbøl, Julie Derving, Hansen, Thomas, Bain, Stephen C

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 299 KB

english, 2017

4

Semaglutide: a promising new glucagon-like peptide-1 receptor agonist

Scheen, André J

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 45 KB

english, 2017

5

The artificial pancreas—ready for prime time?

DeVries, J Hans

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 84 KB

english, 2017

6

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Raal, Frederick J, Hovingh, G Kees, Blom, Dirk, Santos, Raul D, Harada-Shiba, Mariko, Bruckert, Eric, Couture, Patrick, Soran, Handrean, Watts, Gerald F, Kurtz, Christopher, Honarpour, Narimon, Tang,

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 141 KB

english, 2017

7

Limitations of cholesterol lowering with PCSK9 inhibitors

Thompson, Gilbert

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 137 KB

english, 2017

8

Trans identity: out in the open

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 90 KB

english, 2017

9

Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study

Carlsson, Lena M S, Sjöholm, Kajsa, Karlsson, Cecilia, Jacobson, Peter, Andersson-Assarsson, Johanna C, Svensson, Per-Arne, Larsson, Ingrid, Hjorth, Stephan, Neovius, Martin, Taube, Magdalena, Carlsso

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 378 KB

english, 2017

10

Microvascular complications after metabolic surgery

Dimitriadis, George K, Randeva, Harpal S, Miras, Alexander D

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 39 KB

english, 2017

11

Research in brief

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 94 KB

english, 2017

12

Transgender hormone therapy: understanding international variation in practice

Mamoojee, Yaasir, Seal, Leighton J, Quinton, Richard

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 65 KB

english, 2017

13

Sweet success: will sugar taxes improve health?

The Lancet Diabetes & Endocrinology,

Journal:

The Lancet Diabetes & Endocrinology

Year:

2017

Language:

english

File:

PDF, 97 KB

english, 2017